Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Oncoimmunology
|
November 21, 2015
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
Monica Parodi, Marco Pedrazzi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells
Monica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Cancers
|
October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy
Melania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
The Journal of Allergy and Clinical Immunology
|
February 2, 2025
BNT162b2 COVID-19 vaccination elicits the expansion of CD16<sup>+</sup>CD8<sup>+</sup> T cells endowed with natural killer cell features
Claudia De Pasquale, Fabiana Drommi, Alessia Calabrò, et al.
Cancer Research
|
May 13, 2018
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines
Leticía Huergo-Zapico, Monica Parodi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer
|
February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells
Maria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Oncoimmunology
|
November 21, 2015
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
Monica Parodi, Marco Pedrazzi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells
Monica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Cancers
|
October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy
Melania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
The Journal of Allergy and Clinical Immunology
|
February 2, 2025
BNT162b2 COVID-19 vaccination elicits the expansion of CD16<sup>+</sup>CD8<sup>+</sup> T cells endowed with natural killer cell features
Claudia De Pasquale, Fabiana Drommi, Alessia Calabrò, et al.
Cancer Research
|
May 13, 2018
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines
Leticía Huergo-Zapico, Monica Parodi, Claudia Cantoni, et al.
Journal for Immunotherapy of Cancer
|
February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells
Maria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Page
of 8